PHARMATHENE, INC 4
4 · PHARMATHENE, INC · Filed Dec 22, 2016
Insider Transaction Report
Form 4
MACNEILL PHILIP
Controller and PAO
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001 per share
2016-12-21$1.66/sh+17,657$29,311→ 126,346 total - Exercise/Conversion
Employee Stock Option (right to buy)
2016-12-21−17,657→ 35,312 totalExercise: $1.66Exp: 2025-12-03→ Common Stock (17,657 underlying) - Exercise/Conversion
Common Stock, par value $0.0001 per share
2016-12-21$1.71/sh+5,000$8,550→ 108,689 total - Exercise/Conversion
Employee Stock Option (right to buy)
2016-12-21−5,000→ 5,000 totalExercise: $1.71Exp: 2024-12-08→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 8, 2014.
- [F2]These options were granted on December 3, 2015, and vest over a 3 year period with 25% vesting on the grant date and an additional 25% vesting on each of the first, second and third anniversaries of the grant date.